Chinese Medicine

Chinese Medicine is an open access journal published by BMC within Springer Nature, established in 2006 and devoted to evidence based, scientifically justified research on Chinese medicine from phytochemistry and pharmacology to clinical application, with a 2025 Journal Impact Factor of 7.4 and a rank of 29th among 356 pharmacology and pharmacy journals《中医》（Chinese Medicine）是（BMC）在（Springer Nature）旗下出版的全开放获取期刊，2006 年创刊，专注以证据为基础、科学上可辩护的中医药研究，从植物化学与药理学到临床应用，2025 年影响因子 7.4，在 356 种药理学与药学期刊中列第 29 位。

Scope

• Chemistry of Chinese medicinal materials is a foundational area, with emphasis on the discovery and structural elucidation of compounds that have not previously been described中药化学是基础领域，重点在于发现并解析此前未见报道的化合物结构。
• Biology and pharmacology are treated together, with molecular and cellular targets and mechanisms of action expected rather than gross phenotypic descriptions alone生物学与药理学被放在一起考察，要求给出分子与细胞靶点及作用机制，而不只是粗放的表型描述。
• Pharmaceutics and drug delivery are within scope, including modern formulation and molecular pharmaceutic tools designed specifically for Chinese medicine preparations药剂学与给药系统属收稿范围，包括专为中药制剂设计的现代制剂技术与分子药剂学工具。
• Engineering approaches and interdisciplinary methods are welcomed where they let investigators interrogate Chinese medicine with techniques from other fields工程学方法与跨学科手段只要能让研究者借用其他领域的技术研究中医药，即受欢迎。
• Clinical applications are published when studies are hypothesis driven and rationally designed, whether fundamental, preclinical or clinical in setting临床应用类研究须以假说驱动并经合理设计，无论属于基础、临床前还是临床场景。
• Socioeconomic analysis of Chinese medicine, including its provision, cost and role in health systems, is accepted as part of the journal's remit中医药的社会经济分析（含其供给、成本与在卫生体系中的作用）属该刊职责范围。
• Research papers and reviews are published whether solicited or not, while opinion and commentary pieces are by invitation only and case studies, technical notes and meta-analyses are normally excluded研究论文与综述无论约稿与否均可发表，观点与评论类文章仅限约稿，病例研究、技术札记与荟萃分析通常不予刊载。

History

• The journal was established in 2006 by BioMed Central, the open access publisher that has since become part of Springer Nature, making it one of the earlier open access titles in its field该刊 2006 年由（BioMed Central）创办，这家开放获取出版社此后并入（Springer Nature），使其成为本领域较早的开放获取期刊之一。
• It has appeared only online since launch and carries a single identifier, so its content is cited through one ISSN rather than a print and electronic pair该刊自创刊起仅在线上出版并使用单一标识，因此其内容通过一个国际标准刊号引用，而非纸本与电子版双号。
• Publication is continuous, with articles entering an annual volume as soon as they are accepted, and the full text is deposited in PubMed Central该刊连续出版，文章一经录用即进入当年卷次，全文存入（PubMed Central）。
• Authors pay an article processing charge, and the journal is indexed in Science Citation Index Expanded, Scopus and other major databases作者需支付文章处理费，期刊被（Science Citation Index Expanded）、（Scopus）等主要数据库收录。
• Its impact factor moved from 5.455 in 2021 and 4.546 in 2022 to 5.7 in 2024 and 7.4 in 2025, the sharpest rise in its recent history该刊影响因子从 2021 年的 5.455、2022 年的 4.546 升至 2024 年的 5.7 与 2025 年的 7.4，为近年最大涨幅。

Editors

• The editor-in-chief is Yitao Wang, a medical doctor based at the International Society for Chinese Medicine in Macao现任主编为（Yitao Wang），这位医学博士任职于澳门的（International Society for Chinese Medicine）。
• Shilin Chen of Chengdu University of Traditional Chinese Medicine is consulting editor-in-chief, and Jian-Bo Wan of the University of Macau serves as deputy editor（Chengdu University of Traditional Chinese Medicine）的（Shilin Chen）任顾问主编，（University of Macau）的（Jian-Bo Wan）任副编辑。
• Five associate editors cover Hong Kong, Macao, mainland China and the Netherlands, among them Zhaoxiang Bian of Hong Kong Baptist University and Mei Wang of the Netherlands Organisation for Applied Scientific Research五位副编辑分布于香港、澳门、中国内地与荷兰，其中包括（Hong Kong Baptist University）的（Zhaoxiang Bian）与（Netherlands Organisation for Applied Scientific Research）的（Mei Wang）。
• The board of roughly forty members is drawn mainly from Chinese universities and academies, with additional members in the United States, France, Poland and Bulgaria编委会约四十人，主要来自中国高校与科研院所，另有成员分布于美国、法国、波兰与保加利亚。
• Manuscripts are assessed by external experts through the publisher's online system, and the journal asks authors to show that their work is evidence based and scientifically justified rather than descriptive稿件由外部专家通过出版方在线系统评审，期刊并要求作者证明其工作有证据支撑且科学上站得住脚，而非停留于描述。